HB 446 establishes the Dementia Services and Brain Health Program within Maryland’s Department of Health to lead state public health efforts on brain health and dementia. The program replaces the previous "Director" role for key duties, including staffing the Virginia I. Jones Alzheimer’s Disease and Related Dementias Council and overseeing implementation of the State Plan on Alzheimer’s and related dementias. It requires the program, in partnership with the Department of Aging and other entities, to develop a clinical toolkit for healthcare providers to improve dementia care. The bill updates existing law to formalize this program structure and its responsibilities.
SB 370 revises Maryland's acupuncture licensing rules by defining "manual therapies" as part of licensed acupuncture practice and requiring the State Acupuncture Board to provide proof of license renewal instead of issuing physical renewal certificates. The bill prohibits employers from hiring unlicensed acupuncture practitioners or aiding unauthorized practice, with penalties including civil fines up to $50,000 and criminal charges for repeat offenses. It directly affects licensed acupuncturists, their employers, and clinics that hire practitioners, clarifying what constitutes authorized practice under state law. The changes take effect October 1, 2026, and align licensing standards with national certification requirements for new applicants.
SB 394 adds bacterial vaginosis to Maryland's list of conditions eligible for expedited partner therapy (EPT). This allows certain healthcare providers - like physicians, advanced practice nurses, and pharmaciststo prescribe antibiotics to a sexual partner of a diagnosed patient without requiring a personal examination of the partner. The law aims to prevent reinfection in the diagnosed patient and stop disease spread, expanding existing EPT rules that previously covered only chlamydia, gonorrhea, and trichomoniasis. It applies to public and private health care settings in Maryland starting October 1, 2026.
SB 439 prohibits Maryland fire and rescue public safety employers from taking negative employment actions (like firing or denying promotions) against employees who use medical cannabis, provided the employee has a valid medical cannabis certification under state law. It amends existing Maryland law to explicitly add this protection for public safety workers, aligning with current medical cannabis certification requirements. The bill does not change how medical cannabis is certified but ensures these employees cannot face discrimination solely for using cannabis legally under the state program. This applies to all fire and rescue employees who meet the state's medical cannabis eligibility criteria.
SB 336 extends the deadline for the existing Task Force on Responsible Use of Natural Psychedelic Substances, established by 2024 law, to continue its work studying natural psychedelic substances like psilocybin and mescaline (excluding peyote). The task force, composed of state officials, experts, and community representatives, will study current laws, scientific data on benefits and risks, and barriers to access, then make recommendations for a state access program and legal changes. This extension allows the task force to finalize its report on creating equitable access to these substances and transitioning away from criminal penalties for nonviolent uses. The bill does not change current laws but prolongs the study period to inform future policy decisions.
HB 672 amends the Maryland Pediatric Cancer Fund to specify that only nonprofit hospitals, educational institutions, and other nonprofit organizations may receive grants for pediatric cancer research, removing previous eligibility for physicians, laboratories, and individuals. The bill requires grant funds to be used exclusively for direct research costs, prohibiting use for administrative overhead or community-based services. It also mandates annual reporting to the General Assembly on fund administration, promotional efforts, and detailed fund usage.
SB 493 prohibits nursing facilities in Maryland from involuntarily discharging or transferring residents except for specific reasons like the resident's welfare, health improvement, or facility closure. It requires facilities to provide residents with a clear written notice at least 10 days before any involuntary discharge or transfer, detailing the reason, new location, and contact information for hearings and legal assistance. The bill also bans sending residents to temporary housing (like hotels) without confirmation from the receiving facility and prevents facilities from discharging Medicaid-eligible residents solely because they qualify for Medicaid. These changes aim to protect vulnerable residents by ensuring proper notice, preventing unfair treatment, and requiring confirmation before transfers.
SB 562 allows pharmacists in Maryland to treat opioid use disorders using medication therapy under specific conditions. It repeals a requirement that prescribers (like doctors) must submit agreements to their health board and instead authorizes pharmacists to enter into prescriber-pharmacist agreements if they meet qualifications such as holding a Doctor of Pharmacy degree, completing required training, and registering with federal agencies. The law mandates that any treatment protocol requires pharmacists to check the Prescription Drug Monitoring Program before starting or changing medication. This change aims to expand access to medication-based treatment for opioid use disorders by enabling pharmacists to provide care in pharmacy settings.
SB 24 revises Maryland's Public Access Automated External Defibrillator (AED) Program to improve oversight and accessibility. It requires most organizations using public AEDs to appoint an AED coordinator responsible for maintenance, reporting, and emergency notification, while exempting law enforcement agencies from needing certificates for AEDs in patrol vehicles. The bill also repeals outdated requirements for regional AED committees and clarifies that grocery stores and restaurants are not subject to certain AED registration rules. These changes aim to streamline compliance for entities managing public AEDs, including schools, businesses, and public facilities.
HB 276 revises Maryland's Public Access Automated External Defibrillator (AED) Program to clarify requirements for entities using AEDs. It establishes a mandatory "AED Coordinator" role to maintain AED functionality and reporting, repeals outdated requirements for regional council AED committees, and exempts law enforcement agencies from needing a certificate for AEDs deployed in patrol vehicles. The bill affects businesses, organizations, and government entities that operate public AEDs, requiring them to maintain written AED plans and coordinate with emergency services. Key changes streamline oversight while ensuring AEDs remain accessible and properly maintained for public use during cardiac emergencies.
